Latest SHINE Technologies News & Updates
See the latest news and media coverage for SHINE. We track all announcements, press releases, and industry mentions in real time, all in one place.
Nuclear fusion technology developer
shinefusion.com- Headquarters
- Janesville, United States
- Founded year
- 2005
- Company type
- Private company
- Number of employees
- 300–500
Latest news about SHINE Technologies (SHINE)
Company announcements
-
SHINE receives $263M conditional DOE loan for Chrysalis
The loan supports completion of the Janesville facility, the world's largest medical isotope production plant. CEO Greg Piefer highlights fusion's current applications in safety and medicine.
-
SHINE receives conditional $263M DOE loan commitment
The financing supports Chrysalis, the world's largest medical isotope facility using fusion technology for domestic Mo-99 production. It addresses supply vulnerabilities and creates jobs.
-
SHINE announces strategic partnership with C-Ray Therapeutics
The agreement establishes C-Ray as exclusive distributor of SHINE's non-carrier-added Lu-177 in mainland China, enhancing access to cancer therapy isotopes.
-
SHINE raises $240 million in equity funding
The round, led by Dr. Patrick Soon-Shiong who joins the board, supports fusion technology advancement. Investors include Fidelity, Sumitomo, and others.
Media coverage
-
Janesville nuclear fusion company picked for $263 million federal loan
The loan would go toward SHINE Technologies’ vast medical isotope production facility in Janesville.
-
Conditional funding announced for US fusion-based isotope facility
The award to SHINE Chrysalis LLC, through the Department of Energy's Office of Energy Dominance Financing, is dependent on the company satisfying technical, legal, environmental...
-
SHINE Receives Conditional Commitment for $263 Million DOE Loan to Scale Domestic Medical Isotope Manufacturing Using Fusion Technology
Financing will support completion of Chrysalis, the world's largest medical isotope production facility, establishing first commercial supply of molybdenum-99 JANESVILLE, Wis., April 9, 2026 ...
-
SHINE and C-Ray Therapeutics Establish Strategic Partnership for Exclusive Distribution of Non-Carrier-Added Lu-177 in Mainland China
Partnership brings reliable access to a critical cancer therapy isotope to one of the world's largest and fastest-growing oncology markets JANESVILLE, Wis. and CHENGDU, China...
Track SHINE and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore
BlueConic
Amperity
Wero
BLIK
EPI
Swish
Affirm
Brite Payments
TCS
Overview Energy
Adfin
Ineffable Intelligence
Mechanize
Hexatronic
Alimak Group
Lindab Group
NYAB
Noon Energy
Nordan AI
Mips
Vexlum
Asker Healthcare Group
FAKRO